Fa'atatau i lo matou tomai i peptide, fa'atasi ai ma le matou R&D fa'avae malosi, matou i Hybio ofo atu peptides fa'apitoa e eseese lavelave. O nei mea o lo'o tu'ufa'atasia i le fa'aogaina o fa'agasologa malo-malō ma vai-vaega e fa'amalieina mana'oga eseese o tatou tagata fa'atau i le lalolagi.
01
E uiga i
Hybio Pharmaceutical Co., Ltd.
Faʻavae i le 1998, Hybio o se kamupani peptides taʻutaʻua i Saina faʻapitoa i le atinaʻeina, gaosiga ma faʻatau pisinisi o peptides therapeutic API ma vailaʻau faʻavae peptide, lisiina i le maketi ma faʻamaumauga faʻatau 300199.
Faatasi ai ma le sili atu i le 20 tausaga o le poto masani, ua ofoina atu e Hybio le tele o oloa gaosi peptide ma auaunaga, faʻapea foʻi ma CRO ma CDMO mo suʻesuʻega, atinaʻe falemaʻi ma faʻatauga faʻapisinisi mo kamupani vailaʻau i le lalolagi atoa. O oloa autu ua faʻaaogaina e togafitia ai faʻamaʻi faʻamaʻi, faʻamaʻi cardio-cerebro-vascular, maʻi suka, faʻamaʻi pipisi, kanesa, ma faʻamaʻi senile, ma isi.
Va'ai atili 
la tatou fofo
Matou te tuuina atu ia te oeCRO&CDMO
Matou te ofoina atu le tele o peptides i le lalolagi atoa, e pei o Liraglutide, Semaglutide ma Exenatide mo le maʻisuka; Terlipressin, Desmopressin ma Linaclotide mo le digestive tract ma metabolic system; Ganirelix, Cetrorelix ma Atosiban mo obstetrics ma gynecology, ma isi.
O TATOU TULAGA
O le tatou tauvaga autui le 2011, na lisiina Hybio i Shenzhen Stock Exchange Market (code code 300199), ma avea ma pisinisi muamua lisiina o le gaosiga o vailaʻau peptide i Saina.
Va'ai atili-
US FDA Faamaonia
API site/FDF site/R&D site
-
200+
Tuuina atu i le 200+ kamupani talavai
-
160+
Vaega R&D o 160+
-
30+ API
Portfolio e aofia ai le 30+ API
-
10+ cGMP
10+ cGMP fa'atagaga na maua mai lala sooupu fa'ava-o-malo GMP
-
20+ DMFs
20+ DMF na faila i pulega eseese
-
100+ atunuu
Auai i le 100+ atunuu e aofia ai US, Europa ma isi vaega o le lalolagi
-
5
5 Fale fa'aonaponei
-
410
410+ Pateni Na Maua



